Pneumococcal conjugate second or third-dose vaccines (PCVc) in Burundi
Burundi: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 88.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Burundi, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Burundi stood at 88.0%.
The figure is down 6.4% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Burundi peaked at 96.0% in 2012 and was at its lowest, 0.0%, in 2008.
That places Burundi 81st out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Burundi, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 14.0% | — |
| 2012 | 96.0% | +585.7% |
| 2013 | 96.0% | +0.0% |
| 2014 | 95.0% | -1.0% |
| 2015 | 94.0% | -1.1% |
| 2016 | 94.0% | +0.0% |
| 2017 | 91.0% | -3.2% |
| 2018 | 90.0% | -1.1% |
| 2019 | 93.0% | +3.3% |
| 2020 | 93.0% | +0.0% |
| 2021 | 94.0% | +1.1% |
| 2022 | 91.0% | -3.2% |
| 2023 | 88.0% | -3.3% |
| 2024 | 88.0% | +0.0% |
| 2025 | 88.0% | +0.0% |
Burundi compared with similar countries
- Burundi's 88.0% is above the median for low income countries, which is 80.0%, 1.1× the median. (25 countries reporting)
- Burundi's 88.0% is above the median for Sub-Saharan Africa, which is 82.5%, 1.1× the median. (48 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Burundi changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2012 | +585.7% | 14.0% | 96.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 76.3% | 0.0% | 96.0% | 10 |
| 2020s | 90.3% | 88.0% | 94.0% | 6 |
Countries ranked near Burundi
More health data for Burundi
- Un projection of annual infant deaths, annual growth rate -1.03 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.1 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 929.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8,143 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 26 (2025)
- Population ages 00-04, female, annual growth rate 0.736 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0003 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0759 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.7548 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0003 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Burundi?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Burundi was 88.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Burundi?
- The highest recorded value was 96.0% in 2012.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Burundi?
- The lowest recorded value was 0.0% in 2008.
- How does Burundi rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Burundi ranks 81st out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Burundi?
- Over the last ten years it is down 6.4%. The long-run trend across the full record is volatile.
- Where does this Burundi data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).